Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 98887Q104 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
TCG Crossover GP II, LLC
13G
|
5.3% |
6/11/2026
Event 6/2/2026
|
|
| TCG Crossover GP II, LLC | 2.6% | ||
| TCG Crossover Fund II, L.P. | 2.6% | ||
| TCG Crossover GP III, LLC | 2.6% | ||
| TCG Crossover Fund III, L.P. | 2.6% | ||
| Chen Yu | 5.3% | ||
|
RA Capital Management, L.P.
13G
|
5.2% |
4/6/2026
Event 3/30/2026
|
|
| RA Capital Management, L.P. | 5.2% | ||
| Peter Kolchinsky | 5.2% | ||
| Rajeev Shah | 5.2% | ||
| RA Capital Healthcare Fund, L.P. | 5.2% | ||
|
RTW Investments, LP
13G
|
6.3% |
2/17/2026
Event 12/31/2025
|
|
| RTW Investments, LP | 6.3% | ||
| Roderick Wong | 6.3% | ||
|
Qiming Corporate GP IV, Ltd
13G/A
Amendment 6
|
4.4% |
2/13/2026
Event 12/31/2025
|
|
| Qiming Corporate GP IV, Ltd. | 4.4% | ||
| Qiming Managing Directors Fund IV, L.P. | 0.1% | ||
| Qiming GP IV, L.P. | 4.2% | ||
| Qiming Venture Partners IV, L.P. | 4.2% | ||
| QM11 Limited | 4.4% | ||
|
RTW Investments, LP
13G/A
Amendment 1
|
2.1% |
11/14/2025
Event 9/30/2025
|
|
| RTW Investments, LP | 2.1% | ||
| Roderick Wong | 2.1% | ||
|
RTW Investments, LP
13G
|
5.1% |
8/14/2025
Event 6/30/2025
|
|
| RTW Investments, LP | 5.1% | ||
| Roderick Wong | 5.1% | ||
|
Qiming Venture Partners IV, L.P.
13G/A
Amendment 5
|
6.0% |
8/12/2025
Event 6/30/2025
|
|
| Qiming Corporate GP IV, Ltd. | 6.0% | ||
| Qiming Managing Directors Fund IV, L.P | 0.2% | ||
| Qiming GP IV, L.P | 5.8% | ||
| Qiming Venture Partners IV, L.P. | 5.8% | ||
| QM11 Limited | 6.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 372 | $9.80 k |
| 2026 Q2 | 96 | 43.3 M | $823 M |
| 2026 Q1 | 105 | 28.2 M | $531 M |
| 2025 Q4 | 133 | 28.9 M | $511 M |
| 2025 Q3 | 150 | 35.2 M | $1.19 B |
| 2025 Q2 | 168 | 42.9 M | $1.50 B |
| 2025 Q1 | 174 | 56.5 M | $1.97 B |
| 2024 Q4 | 145 | 56.4 M | $1.48 B |
| 2024 Q3 | 119 | 45.4 M | $1.10 B |
| 2024 Q2 | 118 | 41.4 M | $717 M |
| 2024 Q1 | 131 | 41.8 M | $669 M |
| 2023 Q4 | 139 | 41.7 M | $1.14 B |
| 2023 Q3 | 127 | 39.4 M | $954 M |
| 2023 Q2 | 148 | 42.8 M | $1.18 B |
| 2023 Q1 | 175 | 53.0 M | $1.75 B |
| 2022 Q4 | 175 | 59.7 M | $1.85 B |
| 2022 Q3 | 180 | 61.5 M | $2.11 B |
| 2022 Q2 | 174 | 60.7 M | $2.11 B |
| 2022 Q1 | 190 | 62.0 M | $2.74 B |
| 2021 Q4 | 226 | 64.7 M | $4.07 B |
| 2021 Q3 | 242 | 64.1 M | $6.76 B |
| 2021 Q2 | 254 | 62.3 M | $11.0 B |
| 2021 Q1 | 238 | 54.4 M | $7.24 B |
| 2020 Q4 | 205 | 54.1 M | $7.32 B |
| 2020 Q3 | 191 | 50.2 M | $4.16 B |
| 2020 Q2 | 183 | 48.5 M | $3.98 B |
| 2020 Q1 | 149 | 46.5 M | $2.39 B |
| 2019 Q4 | 110 | 37.8 M | $1.57 B |
| 2019 Q3 | 94 | 37.4 M | $1.21 B |
| 2019 Q2 | 88 | 35.9 M | $1.25 B |
| 2019 Q1 | 74 | 21.2 M | $626 M |
| 2018 Q4 | 63 | 21.2 M | $493 M |
| 2018 Q3 | 64 | 20.7 M | $403 M |
| 2018 Q2 | 40 | 12.3 M | $287 M |
| 2018 Q1 | 36 | 10.8 M | $231 M |
| 2017 Q4 | 33 | 10.4 M | $220 M |
| 2017 Q3 | 47 | 9.15 M | $247 M |